Acta Vet. Brno 2018, 87: 231-240

https://doi.org/10.2754/avb201887030231

Hyaluronic acid and TGF-β1 in dogs with hepatobiliary diseases

Václav Ceplecha1, Kristína Řeháková2, Corinne Lendon3, Pavel Proks1,4, Miša Škorič5, Guy C.M. Grinwis6, Barbora Hřibová1, Miloš Vávra1, Jana Lorenzová1,4, Michal Crha1

1University of Veterinary and Pharmaceutical Sciences Brno, Faculty of Veterinary Medicine, Small Animal Clinic, Brno, Czech Republic
2University of Veterinary and Pharmaceutical Sciences Brno, Faculty of Veterinary Medicine, Small Animal Clinical Laboratory, Brno, Czech Republic
3Edith Cowan University, Research & Innovation, Joondalup, WA, Australia
4CEITEC - Central European Institute of Technology, Brno, Czech Republic
5University of Veterinary and Pharmaceutical Sciences Brno, Faculty of Veterinary Medicine, Department of Pathological Morphology and Parasitology, Brno, Czech Republic
6University of Utrecht, Faculty of Veterinary Medicine, Department of Pathobiology, Utrecht, the Netherlands

Received June 26, 2018
Accepted August 13, 2018

References

1. Arican M, Carter SD, May C, Bennett D 1994: Hyaluronan in canine arthropathies. J Comp Pathol 111: 185-195 <https://doi.org/10.1016/S0021-9975(05)80050-7>
2. Bataller R, Brenner DA 2005: Liver fibrosis. J Clin Invest 115: 209-218 <https://doi.org/10.1172/JCI24282>
3. d’Anjou MA 2015: Liver. In: Penninck D, d’Anjou MA (Eds): Atlas of Small Animal Ultrasonography, 2nd edn, Blackwell Publishing, Ames, pp. 217-261
4. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ 1994: Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 19: 1513-1520 <https://doi.org/10.1002/hep.1840190629>
5. Glinska-Suchocka K, Orlowska A, Spuzak J, Jankowski M, Kubiak K 2015: Suitability of using serum hialuronic acid concentrations in the diagnosis of canine liver fibrosis. Pol J Vet Sci 18: 873-878 <https://doi.org/10.1515/pjvs-2015-0113>
6. Kanemoto H, Ohno K, Sakai M, Nakashima K, Takahashi M, Fujino Y, Tsujimoto H 2009: Blood hyaluronic acid as a marker for canine cirrhosis. J Vet Med Sci 71: 1251-1254 <https://doi.org/10.1292/jvms.71.1251>
7. Kemp SD, Panciera DL, Larson MM, Saunders GK, Werre SR 2013: A comparison of hepatic sonographic features and histopathologic diagnosis in canine liver disease: 138 cases. J Vet Intern Med 27: 806-813 <https://doi.org/10.1111/jvim.12091>
8. Lee HH, Seo YS, Um SH, Won NH, Yoo H, Jung ES, Kwon YD, Park S, Keum B, Kim YS, Yim HJ, Jeen YT, Chun HJ, Kim CD, Ryu HS 2010: Usefulness of non-invasive markers for predicting significant fibrosis in patients with chronic liver disease. Journal of Korean Medical Science 25: 67-74 <https://doi.org/10.3346/jkms.2010.25.1.67>
9. Lidbury JA, Hoffmann AR, Fry JK, Suchodolski JS, Steiner JM 2016: Evaluation of hyaluronic acid, procollagen type III N-terminal peptide, and tissue inhibitor of matrix metalloproteinase-1 as serum markers of canine hepatic fibrosis. Can J Vet Res 80: 302-308
10. Liu T, Wang X, Karsdal MA, Leeming DJ, Genovese F 2012: Molecular Serum Markers of Liver Fibrosis. Biomark Insights 7: 105-117 <https://doi.org/10.4137/BMI.S10009>
11. Maiolini A, Otten M, Hewicker-Trautwein M, Carlson R, Tipold A 2013: Interleukin-6, vascular endothelial growth factor and transforming growth factor beta 1 in canine steroid responsive meningitis-arteritis. BMC Vet Res 9: 23 <https://doi.org/10.1186/1746-6148-9-23>
12. McGary CT, Raja RH, Weigel PH 1989: Endocytosis of hyaluronic acid by rat liver endothelial cells. Evidence for receptor recycling. Biochem J 257: 875-884 <https://doi.org/10.1042/bj2570875>
13. Nelson DR, Gonzalez-Peralta RP, Qian K, Xu Y, Marousis CG, Davis GL, Lau JY 1997: Transforming growth factor-beta 1 in chronic hepatitis C. J Viral Hepat 4: 29-35 <https://doi.org/10.1046/j.1365-2893.1997.00124.x>
14. Neumann S, Kaup F-J, Beardi B 2008: Plasma concentration of transforming growth factor-β1 and hepatic fibrosis in dogs. Can J Vet Res 72: 428-431
15. Oberti F, Valsesia E, Pilette C, Rousselet MC, Bedossa P, Aube C, Gallois Y, Rifflet H, Maiga MY, Penneau-Fontbonne D, Cales P 1997: Noninvasive diagnosis of hepatic fibrosis or cirrhosis. Gastroenterology 113: 1609-1616 <https://doi.org/10.1053/gast.1997.v113.pm9352863>
16. Poldervaart JH, Favier RP, Penning LC, Van Den Ingh TSGAM, Rothuizen J 2009: Primary Hepatitis in Dogs: A Retrospective Review (2002–2006). J Vet Intern Med 23: 72-80 <https://doi.org/10.1111/j.1939-1676.2008.0215.x>
17. Rosenberg WMC, Voelker M, Thiel R, Becka M, Burt A, Schuppan D, Hubscher S, Roskams T, Pinzani M, Arthur MJP 2004: Serum markers detect the presence of liver fibrosis: A cohort study. Gastroenterology 127: 1704-1713 <https://doi.org/10.1053/j.gastro.2004.08.052>
18. Rothuizen J 2006: Chapter 1 - Introduction - background, aims and methods. In: Rothuizen J, Bunch SE, Charles JA, Cullen JM, Desmet VJ, Szatmári V, Twedt DC, van den Ingh TSGAM, Van Winkle T, Washabau RJ (Eds): WSAVA Standards for Clinical and Histological Diagnosis of Canine and Feline Liver Diseases. W.B. Saunders, Edinburgh, pp. 1-4
19. Sebastiani G, Alberti A 2006: Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy. World J Gastroenterol 12: 3682-3694 <https://doi.org/10.3748/wjg.v12.i23.3682>
20. Seki M, Asano K, Sakai M, Kanno N, Teshima K, Edamura K, Tanaka S 2010: Serum hyaluronic acid in dogs with congenital portosystemic shunts. J Small Anim Pract 51: 260-263 <https://doi.org/10.1111/j.1748-5827.2010.00934.x>
21. Stickel F, Poeschl G, Schuppan D, Conradt C, Strenge-Hesse A, Fuchs FS, Hofmann WJ, Seitz HK 2003: Serum hyaluronate correlates with histological progression in alcoholic liver disease. Eur J Gastroenterol Hepatol 15: 945-950 <https://doi.org/10.1097/00042737-200309000-00002>
22. Wong VS, Hughes V, Trull A, Wight DG, Petrik J, Alexander GJ 1998: Serum hyaluronic acid is a useful marker of liver fibrosis in chronic hepatitis C virus infection. J Viral Hepat 5: 187-192 <https://doi.org/10.1046/j.1365-2893.1998.00100.x>
front cover
  • ISSN 0001-7213 (printed)
  • ISSN 1801-7576 (electronic)

Current issue

Archive